CYCN - Cyclerion Therapeutics Inc
Previous close
3.15
0 0%
Share volume: 292
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.15
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
| Report Date | 2022-05-04 | 2022-08-09 | 2022-11-03 | 2023-03-22 | 2023-05-12 | 2023-07-28 | 2023-11-13 | |
| Cash flow financing | 0.000 | 17.000 K | 0.000 | 12.000 K | 0.000 | 5.024 M | 0.000 | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -12.835 M | -10.818 M | -9.915 M | -7.043 M | -6.214 M | -6.555 M | -6.935 M | |
| Net income | -12.978 M | -13.388 M | -10.496 M | -7.216 M | -6.954 M | -4.181 M | 7.566 M | |
| Depreciation | 48.000 K | 17.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 227.000 K | 227.000 K | 227.000 K | 96.000 K | 96.000 K | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 10.402 M | |
| Net Borrowings | -42.609 M | -31.452 M | -21.429 M | -14.724 M | -8.239 M | -7.113 M | -9.864 M | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | 41.125 M | 30.323 M | 20.405 M | 13.382 M | 7.169 M | 5.641 M | 9.108 M |